November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Evaluating Pharmacokinetic Profiles of Mitomycin-C Regimens in Hyperthermic Intraperitoneal Chemotherapy

🧠 AI Analysis 2 min read 👁 0

Researchers compared three distinct mitomycin-C dosing regimens for hyperthermic intraperitoneal chemotherapy using a rat model, finding differences in plasma levels but similar peritoneal concentrations.

🧠AI Analysis

Key points

  • Compared three mitomycin-C HIPEC regimens in a rat model
  • Group 1 demonstrated lower plasma concentrations with divided dosing
  • Peritoneal-to-plasma AUC ratios showed no significant differences

A team of researchers has evaluated the pharmacokinetic properties of three different mitomycin-C (MMC) regimens utilized in hyperthermic intraperitoneal chemotherapy (HIPEC), a treatment approach frequently applied for colorectal peritoneal metastases. The experimental study utilized eighteen male Sprague–Dawley rats, which were randomized into three distinct groups for a 90-minute procedure at 41–42℃. Group 1 was given 35 mg/m² divided into three doses at 0, 30, and 60 minutes; Group 2 received 40 mg/m² split into two doses at 0 and 60 minutes; and Group 3 was administered a single bolus dose of 35 mg/m² at the start of perfusion. Investigators measured both peritoneal fluid and plasma concentrations using liquid chromatography-tandem mass spectrometry.

The findings indicate that MMC concentrations varied significantly across the three protocols over the 90-minute perfusion period. However, final peritoneal concentrations at the 90-minute mark remained comparable among the cohorts, registering at 73.63, 75.92, and 79.58 ng/mL respectively. Notably, plasma concentration was lower in Group 1 at 1.59 ng/mL compared to 2.45 and 2.02 ng/mL in the other groups. The peritoneal-to-plasma area under the curve (AUC) ratios showed no statistically significant divergence across the regimens. Experts note that animal model studies represent early-stage investigations, and caution that these pharmacological findings cannot be directly extrapolated to human clinical practices without further human trials.

What to know: While divided dosing schedules may lower systemic plasma exposure of mitomycin-C during HIPEC, peritoneal levels and overall AUC ratios remained similar across the tested methods. Always consult a qualified medical professional for guidance regarding cancer treatments and surgical protocols.

Source Nature Health Sciences — nature.com/articles/s41598-026-80723-7 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.